Novo Nordisk (NYSE: NVO), the Danish company best known as the maker of weight loss drug Wegovy, expanded a little on the ...
16h
MarketBeat on MSNIs Viking Therapeutics the Next Blockbuster GLP-1 Stock?When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing ...
US biopharma Viking Therapeutics developing therapies for metabolic and endocrine disorders, closed Tuesday’s trading 5% ...
This long-term agreement will help support the commercialization of VK2735.
The deal provides Viking Therapeutics with a secured dedicated annual supply of both injectable and oral versions of its ...
Viking Therapeutics inks broad manufacturing pact with CordenPharma to support commercialization of VK2735: San Diego Wednesday, March 12, 2025, 17:00 Hrs [IST] Viking Therapeutic ...
After Viking Therapeutics (VKTX) announced a multi-year manufacturing agreement with CordenPharma to support the commercialization of VK2735, ...
Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results